1. Home
  2. DTSQ vs IOBT Comparison

DTSQ vs IOBT Comparison

Compare DTSQ & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DTSQ
  • IOBT
  • Stock Information
  • Founded
  • DTSQ 2022
  • IOBT 2014
  • Country
  • DTSQ United States
  • IOBT Denmark
  • Employees
  • DTSQ N/A
  • IOBT N/A
  • Industry
  • DTSQ
  • IOBT Biotechnology: Pharmaceutical Preparations
  • Sector
  • DTSQ
  • IOBT Health Care
  • Exchange
  • DTSQ NYSE
  • IOBT Nasdaq
  • Market Cap
  • DTSQ 91.7M
  • IOBT 91.6M
  • IPO Year
  • DTSQ 2024
  • IOBT 2021
  • Fundamental
  • Price
  • DTSQ $10.39
  • IOBT $1.79
  • Analyst Decision
  • DTSQ
  • IOBT Strong Buy
  • Analyst Count
  • DTSQ 0
  • IOBT 3
  • Target Price
  • DTSQ N/A
  • IOBT $9.33
  • AVG Volume (30 Days)
  • DTSQ 775.0
  • IOBT 231.3K
  • Earning Date
  • DTSQ 01-01-0001
  • IOBT 08-12-2025
  • Dividend Yield
  • DTSQ N/A
  • IOBT N/A
  • EPS Growth
  • DTSQ N/A
  • IOBT N/A
  • EPS
  • DTSQ 0.28
  • IOBT N/A
  • Revenue
  • DTSQ N/A
  • IOBT N/A
  • Revenue This Year
  • DTSQ N/A
  • IOBT N/A
  • Revenue Next Year
  • DTSQ N/A
  • IOBT N/A
  • P/E Ratio
  • DTSQ $37.10
  • IOBT N/A
  • Revenue Growth
  • DTSQ N/A
  • IOBT N/A
  • 52 Week Low
  • DTSQ $9.96
  • IOBT $0.66
  • 52 Week High
  • DTSQ $10.47
  • IOBT $1.90
  • Technical
  • Relative Strength Index (RSI)
  • DTSQ N/A
  • IOBT 68.80
  • Support Level
  • DTSQ N/A
  • IOBT $1.34
  • Resistance Level
  • DTSQ N/A
  • IOBT $1.74
  • Average True Range (ATR)
  • DTSQ 0.00
  • IOBT 0.11
  • MACD
  • DTSQ 0.00
  • IOBT 0.02
  • Stochastic Oscillator
  • DTSQ 0.00
  • IOBT 93.18

About DTSQ DT CLOUD STAR ACQUISITION CORP

DT Cloud Star Acquisition Corp is a blank check company.

About IOBT IO Biotech Inc.

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Share on Social Networks: